Fabian Johannes Eber

Title: Fabian Johannes Eber: Innovator in Long-Chain RNA Formulations

Introduction

Fabian Johannes Eber is a prominent inventor based in Stuttgart, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of formulations involving long-chain RNA. With a total of 12 patents to his name, Eber's work is paving the way for advancements in pharmaceutical compositions and vaccines.

Latest Patents

Eber's latest patents focus on dry powder compositions comprising long-chain RNA. One of his notable inventions is directed to a storage-stable formulation of long-chain RNA. This invention includes methods for preparing a dry powder composition through spray-drying techniques. Additionally, it addresses the use of such compositions in the preparation of pharmaceutical formulations and vaccines. Another patent involves methods for preparing dry powder compositions using spray-freeze drying, further enhancing the stability and usability of long-chain RNA in medical applications.

Career Highlights

Throughout his career, Eber has worked with notable companies such as CureVac AG and CureVac SE. His experience in these organizations has allowed him to collaborate on innovative projects that leverage his expertise in RNA technology. His contributions have been instrumental in advancing the understanding and application of RNA in therapeutic contexts.

Collaborations

Eber has collaborated with several professionals in his field, including Stefanie Sewing and Thorsten Mutzke. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Fabian Johannes Eber is a key figure in the development of long-chain RNA formulations, with a strong portfolio of patents that reflect his innovative spirit. His work continues to influence the biotechnology landscape, particularly in the realm of pharmaceuticals and vaccines.